Navigation Links
Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma
Date:6/2/2008

CHICAGO and REGENSBURG, Germany, June 2 /PRNewswire/ -- The TGF-beta 2 inhibitor AP 12009, developed by Antisense Pharma, reveals very good safety and tolerability in the systemic treatment of pancreatic carcinoma, malignant melanoma and colorectal carcinoma. AP 12009, administered intravenously, showed a clear proof of concept. Patients with stage IV pancreatic carcinoma, who received AP 12009 for seven days every other week as second or third line therapy, had a median survival time of 29.6 weeks (6.8 months) after start of AP 12009 treatment. One of these patients with several liver metastases even experienced a complete response. Efficacy and safety results of the multicenter Phase I/II study were published today at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, USA (1).

In the open-label, multicenter, dose-escalation Phase I/II study patients with advanced stage pancreatic carcinoma, malignant melanoma or colorectal carcinoma were included. So far 25 patients have been treated in six cohorts. The first four cohorts received AP 12009 as 7-day on, 7-day off cycles. For this schedule, the maximum tolerated dose (MTD) was reached with two grade III thrombocytopenias as dose-limiting toxicities (DLT). These were self-limiting and required no therapeutic intervention. The third DLT was a grade III rash. Thus, the compound AP 12009 revealed excellent safety and tolerability. Very encouraging case reports were observed. One patient, diagnosed with stage IV malignant melanoma, survived more than 60 weeks after the start of AP 12009 treatment. Another patient with stage IV pancreatic carcinoma and several liver metastases had a complete response and is still alive as of March 2008 148 weeks (34 months) after the start of treatment with AP 12009.

After reaching the MTD with the 7-day on, 7-day off schedule, a second schedule with 4-day on, 10-day off cycles was initiated. Two cohorts with a total of seven patients h
'/>"/>

SOURCE Antisense Pharma GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
2. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
3. Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
4. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
5. Amikacin Inhale Shows Promising Results in Phase II Study
6. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
7. New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
8. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
9. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
10. St. Jude Study Shows How T Cells Machinery Dials Down Autoimmunity
11. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Pharmaceutical ... new drugs and tests, and this is ... instruments that can assist them. This according to ... Information said instruments such as mass spectrometry, ... in the identification of drug targets and ...
(Date:5/28/2015)... , May 28, 2015 ... announced the addition of Jain PharmaBiotech,s new ...  to their offering.       ... or gene silencing involves the use of ... cell, this material is processed into short ...
(Date:5/28/2015)... ( http://maetrics.com ), a leading international consulting firm focused ... conference, "The cost of non-compliance -- How new regulation is ... Zurich . Hosted by Maetrics ... -based team, experts provided insights on the impact ... exclusive local audience. The event was held in conjunction ...
Breaking Medicine Technology:Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... N.J., Sept. 27 The American Chemical Society, Informex, and ... to partner in hosting the , ACS Careers Virtual Career ... virtual event, to be held November 2 -3, ... scientific society, chose to work with Informex , the ...
... healthcare market research company ... Online Health Video : Understanding Consumption Patterns to ... health video and the impact of this format on ... significantly among U.S. consumers online for prescription drug information ...
Cached Medicine Technology:Announcing the Inaugural ACS Careers' Virtual Career Fair in Conjunction with Informex and C&EN 2Announcing the Inaugural ACS Careers' Virtual Career Fair in Conjunction with Informex and C&EN 3Announcing the Inaugural ACS Careers' Virtual Career Fair in Conjunction with Informex and C&EN 4New Manhattan Research Report Explores the Growing Consumer Demand for Online Health Video and How Pharma Marketers Can Leverage this Format 2
(Date:5/28/2015)... Falls Church, VA (PRWEB) May 28, 2015 ... Roadmap to the 351(k) Application Process, **FDAnews Webinar**, ... p.m. EDT, [http://www.fdanews.com/BiosimilarsApproval , On June ... and expertise of two leading intellectual property attorneys ... the webinar Success Strategies for Biosimilars Approval: A ...
(Date:5/28/2015)... 28, 2015 On Sunday, June 21, ... a team event to honor the strength, passion and ... summer solstice, the duration of this sunrise-to-sunset event symbolizes ... and their caregivers. Participants raise funds and awareness to ... Alzheimer’s Association. , Teams are encouraged to create their ...
(Date:5/28/2015)... 28, 2015 Park Cities Pet Sitter is ... Training class starting Saturday, June 6th at 10:30am. ... 5831 McCommas Blvd in Dallas, with a maximum of six ... for five weeks, with no class being held over the ... $135. , In this Intermediate-to-Advanced level class, dogs will solidify ...
(Date:5/28/2015)... Restricting access to firearms for people ... that more clearly define alcohol misuse should be developed ... research and public policies by the UC Davis Violence ... 30 in the peer-reviewed journal Preventive Medicine , ... alcohol misuse in association with firearm access and use, ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 The Boys ... of $2,500 from Horizon Blue Cross Blue Shield of New ... golfer Natalie Gulbis, the club can receive much more support ... by Acer. , A former Boys & Girls Club member ... in Sacramento, California, Ms. Gulbis has accepted the Horizon Blue ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 2Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 4Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 2Health News:Golf Pro Natalie Gulbis to Chip in with Horizon Blue Cross Blue Shield of New Jersey to Support Boys & Girls Club of Atlantic City 3
... spinal fusions, but experts worry about costs and complications, , ... agent that stimulates the creation of new bone as part ... United States, although costs and some complication rates also appear ... , The therapeutic agent, known as bone-morphogenic protein, or BMP, ...
... can cause liver damage, even death, if used improperly , ... Tuesday to lower the maximum dose of over-the-counter acetaminophen -- ... medications. , The advisers, vote followed the release of a ... that severe liver damage and even death can result from ...
... how patients interpret results, researchers say , TUESDAY, June ... cancer appears to offer some benefits to patients, according ... online test among 44 smokers. , "Up until now ... You see a professional genetics counselor, undergo a battery ...
... 30 At the 8th Annual Spirit of Entrepreneurship ... Texas (EFNT) recognized The Beryl Companies, the nation,s leading ... as the North Star 2009 Inductee. This award is ... show the importance of giving back to our community ...
... lead to serious injury , , , CHICAGO, ... of skateboarding. They learn to master their skills of "riding ... College of Foot and Ankle Surgeons (ACFAS), such tricks, while ... ankle injuries. , , Foot and ankle surgeons ...
... , VIENNA, Va., June 30 CEL-SCI Corporation ... immunotherapy company, today announced that it has completed a registered ... million before deducting placement agent fees and estimated offering expenses. ... 24, 2009 when the Company entered into definitive agreements, was ...
Cached Medicine News:Health News:Assessment of Bone Growth Stimulator Is Mixed 2Health News:Assessment of Bone Growth Stimulator Is Mixed 3Health News:FDA Advisers Urge Smaller Doses of Acetaminophen 2Health News:FDA Advisers Urge Smaller Doses of Acetaminophen 3Health News:Online Genetic Testing Appears to Have Benefits 2Health News:Beryl Receives Entrepreneurs Foundation of North Texas North Star Recognition 2Health News:Surgeons Warn: Skateboarding Tough on Feet, Ankles 2Health News:CEL-SCI Completes $5.85 Million Registered Direct Offering 2Health News:CEL-SCI Completes $5.85 Million Registered Direct Offering 3
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The ThermoWrap™ enables true normothermia (36.5°C - 37.5°C), induced hypothermia and precise rewarming....
The full body blanket provides coverage to the entire patient....
Medicine Products: